|
Nobel Prize to HPV Researcher Highlights Importance of Cervical Cancer Screening and Prevention
07 October 2008
The Nobel Prize-winning discovery of the causal link between human papillomavirus (HPV) and cervical cancer has spurred lifesaving prevention technologies – such as HPV testing and HPV vaccines - that are helping to eradicate cervical cancer globally.
|
|
|
|
CCS Cell Culture Service and Cytocentrics Agree Cooperation in the Field of Cell Line Development
06 October 2008
The agreement is aimed at the development of electrophysiologically optimized ion channel cell lines which allow a reliable testing of substances and drugs.
|
|
|
|
454 Life Sciences and GenomeQuest Team Up to Provide Next-Generation Sequence Search and Analysis Services
03 October 2008
GenomeQuest will offer On-Demand Informatics Service to users of the 454 Genome Sequencer FLX System under a co-marketing agreement.
|
|
|
|
Horizon Discovery Sign Screening and License Agreements with Agios Pharmaceuticals
01 October 2008
The agreements cover the licensing of certain X-MAN cell lines and the screening of a number of Agios lead compounds on a wide panel of genotypes.
|
|
|
|
Reversible 3-D Cell Culture Gel Invented
30 September 2008
Singapore's scientists have invented a user-friendly gel that can liquefy on demand, with the potential to revolutionize 3D cell culture for medical research.
|
|
|
|
Exco InTouch’s Electronic Patient Diary Selected by Synairgen to Capture ePRO Data in IFN-beta Asthma Trial
30 September 2008
Exco InTouch announces that its electronic patient reported outcomes (ePRO) solutions have been selected by Synairgen, a drug discovery company focused on asthma and chronic obstructive pulmonary disease (COPD).
|
|
|
|
Tissue Proteomics Technology to Identify Protein Biomarkers of Metastasis
29 September 2008
Expression Pathology will collaborate with the Alberta Cancer Board, Tom Baker Cancer Centre (Calgary, Alberta) to identify protein biomarkers of breast cancer metastasis.
|
|
|
|
Monash University Purchases Rigaku CrystalMation system for The Protein Crystallography Unit
26 September 2008
The system is chosen in support of macromolecular crystallographic studies carried out by researchers at Monash University and their collaborative partners.
|
|
|
|
Gene Variant Boosts Risk of Fatty Liver Disease
26 September 2008
Researchers at UT Southwestern Medical Center have found that individuals who carry a specific form of the gene PNPLA3 have more fat in their livers and a greater risk of developing liver inflammation.
|
|
|
|
MorphoSys Nominates First Pre-Development Program in Antibody Collaboration
25 September 2008
MorphoSys announced today that it has exercised its first option to participate in the development of a therapeutic antibody program within its collaboration with Novartis.
|
|
|
|
InhibOx and the National Foundation for Cancer Research Launch Computational Drug Screening Tool
22 September 2008
Both parties have joined forces to launch a new tool to enable scientists to leverage the computer-aided virtual drug screening technology for cancer drug discovery and development.
|
|
|
|
Tecan and the Monash Antibody Technologies Facility Unveil Custom Monoclonal Antibody Production Facility
17 September 2008
The facility has the capacity to produce thousands of different monoclonal antibodies per year for use in research, diagnostics and therapeutic applications.
|
|
|
|
Applied Biosystems Launches Service Provider Programme for Real-Time RNA Expression Analysis
17 September 2008
Nine organisations are named as service providers for RNA expression analysis.
|
|
|
|
Innovative Automation Solutions for Flow Cytometry, Bioprocessing, and Drug Discovery
16 September 2008
Guava Technologies has teamed up with the Hudson Control Group to provide scientists with a unique integrated cellular analysis platform that delivers new levels of throughput and ease-of-use for cell counting, viability, and apoptosis.
|
|
|
|
Calando Pharmaceuticals Announces Next siRNA Therapeutic Candidate for Oncology
15 September 2008
Calando announces development of a second siRNA oncology therapeutic, CALAA-02, targeting HIF-2alpha.
|
|
|
|
deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
15 September 2008
Detection may be used to complement and target screening for the disease; findings will be integrated into the deCODEme™ personal genome scan.
|
|
|
|
OneWorld Health and BioFocus DPI Expand Diarrheal Disease Drug Discovery Collaboration
12 September 2008
BioFocus DPI to performing a high-throughput, cell-based functional screen to identify potential new drugs for the treatment of diarrheal diseases.
|
|
|